<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">762729</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2021.762729</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Lung Adenocarcinoma Cells Promote Self-Migration and Self-Invasion by Activating Neutrophils to Upregulate Notch3 Expression of Cancer Cells</article-title>
<alt-title alt-title-type="left-running-head">Peng et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">TANs Promote Lung Adenocarcinoma Via Notch3</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Peng</surname>
<given-names>Weidong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1301710/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sheng</surname>
<given-names>Youjing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1194180/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Han</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1451547/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ye</surname>
<given-names>Yuanzi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kwantwi</surname>
<given-names>Louis Boafo</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1250696/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cheng</surname>
<given-names>Lanqing</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1203725/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yuanchong</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xu</surname>
<given-names>Jiegou</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1437957/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wu</surname>
<given-names>Qiang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Pathology, The First Affiliated Hospital of Anhui Medical University</institution>, <addr-line>Hefei</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Pathology, School of Basic Medical Science, Anhui Medical University</institution>, <addr-line>Hefei</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Pathology, The Second Affiliated Hospital of Anhui Medical University</institution>, <addr-line>Hefei</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Neonatology, Anhui Provincial Children&#x2019;s Hospital</institution>, <addr-line>Hefei</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Immunology, School of Basic Medical Science, Anhui Medical University</institution>, <addr-line>Hefei</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/619096/overview">Shengtao Zhou</ext-link>, Sichuan University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1488595/overview">Lichun Sun</ext-link>, Harbin Medical University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1386748/overview">Peicheng Li</ext-link>, The First Affiliated Hospital of Soochow University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Qiang Wu, <email>wuqiang@ahmu.edu.cn</email>; Jiegou Xu, <email>xujiegou@ahmu.edu.cn</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work and share first authorship</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Molecular Diagnostics and Therapeutics, a section of the journal Frontiers in Molecular Biosciences</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>01</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>8</volume>
<elocation-id>762729</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>12</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Peng, Sheng, Xiao, Ye, Kwantwi, Cheng, Wang, Xu and Wu.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Peng, Sheng, Xiao, Ye, Kwantwi, Cheng, Wang, Xu and Wu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Background:</bold> Invasion and migration of cancer cells play a key role in lung cancer progression and metastasis. Tumor-associated neutrophils (TANs) are related to poor prognosis in many types of cancer. However, the role of TANs in lung cancer is controversial. In this study, we investigated the effect of TANs on the invasion and migration of lung adenocarcinoma.</p>
<p>
<bold>Methods: </bold>Immunohistochemistry was performed to detect the density of infiltrating TANs and the expression of Notch3 in 100 lung adenocarcinoma tissues. Flow cytometry was used to observe the viability of neutrophils, which were isolated from healthy peripheral blood and then exposed to the supernatant of cultured lung adenocarcinoma cell lines. After treating with tumor-associated neutrophils culture supernatant, NeuCS (supernatant of cultured neutrophils), tumor cells culture supernatant, Medium (serum-free medium), respectively, the migration and invasion of the lung cancer cells before and after transfected by si-Notch3 were detected by transwell assay and wound healing assay. Kaplan-Meier plotter (<ext-link ext-link-type="uri" xlink:href="http://kmplot.com/analysis/index.php?p">http://kmplot.com/analysis/index.php?p</ext-link>) was used to analyze the prognostic role of the density of TANs on lung adenocarcinoma and TIMER ((<ext-link ext-link-type="uri" xlink:href="http://cistrome.dfci.harvard.edu/TIMER/">http://cistrome.dfci.harvard.edu/TIMER/</ext-link>) was used to detect the expression of Notch3 on lung adenocarcinoma.</p>
<p>
<bold>Results:</bold> The infiltration of TANs was observed in the parenchyma and stroma of the lung adenocarcinoma, the density of TANs was positively related to the TNM stage and negatively related to the differentiation and prognosis. Notch3 expression of cancer cells was negatively related to the tumor differentiation and prognosis. Compared to quiescent neutrophils, the viability of TCCS-activated neutrophils was enhanced. Both migration and invasion of A549 and PC9 cells were significantly promoted by TANs, while after knocking down Notch3, the migration and invasion of the cancer cells were not affected by TANs. Bioinformatics analysis showed that the density of TANs and the expression of Notch3 were related to the poor prognosis.</p>
<p>
<bold>Conclusion:</bold> The results indicated that lung adenocarcinoma cells promote self-invasion and self-migration by activating neutrophils to upregulate the Notch3 expression of cancer cells. The density of infiltrating TANs may be a novel marker for the poor prognosis of lung adenocarcinoma. Targeting TANs might be a potential therapeutic strategy for lung cancer treatment.</p>
</abstract>
<kwd-group>
<kwd>lung adenocarcinoma</kwd>
<kwd>Notch3</kwd>
<kwd>migration</kwd>
<kwd>invasion</kwd>
<kwd>tumor-associated neutrophils</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Lung cancer continues to be the most commonly diagnosed cancer type and the leading cause of cancer-related death&#x20;worldwide (<xref ref-type="bibr" rid="B2">Bade and Dela, 2020</xref>). Although the&#x20;overall survival has improved with surgical advances, the 5-years survival rate is still less than 17% (<xref ref-type="bibr" rid="B10">Hirsch et&#x20;al., 2017</xref>). This poor prognostic outcome is primarily attributed to recurrence and metastasis existing in postoperative (<xref ref-type="bibr" rid="B25">Yan et&#x20;al., 2017</xref>). Therefore, exploring further possible prognostic and predictive biomarkers and a potential therapeutic strategy for lung cancer treatment is necessary.</p>
<p>Current evidence has indicated that cross-talk between tumor cells and immune cells creates a unique microenvironment that promotes tumor cell growth, invasion, and metastasis (<xref ref-type="bibr" rid="B30">Zhou et&#x20;al., 2016</xref>). As the most abundant immune cells in the microenvironment, Neutrophils respond to various inflammatory and cancerous signals. Emerging evidence has suggested that tumor-associated neutrophils (TANs) are involved in the malignant progression of several cancer types (<xref ref-type="bibr" rid="B15">Masucci et&#x20;al., 2019</xref>). The infiltration of neutrophils in tumors has been associated with a poor prognosis. In renal cell carcinoma, the infiltration of neutrophils has been shown to correlate with short recurrence-free survival (RFS) and overall survival (OS) in patients (<xref ref-type="bibr" rid="B11">Jensen et&#x20;al., 2009</xref>). Wang et&#x20;al. have indicated that increased intratumoral neutrophils independently predict poor prognostic outcomes in esophageal carcinoma (<xref ref-type="bibr" rid="B21">Wang et&#x20;al., 2014</xref>). However, the role of TANs in lung cancer has been a controversial issue. Carus et&#x20;al. reported the density of CD66b &#x2b; neutrophils has no significant correlation with RFS or OS in non-small cell lung cancer (<xref ref-type="bibr" rid="B5">Carus et&#x20;al., 2013</xref>), While Rakaee et&#x20;al. noted that the density of CD66b &#x2b; TANs to be an independent negative prognostic factor in patients with lung adenocarcinoma (<xref ref-type="bibr" rid="B17">Rakaee et&#x20;al., 2016</xref>). These contradictory observations highlight the diversity of TANs and a pressing need to further evaluate their roles and underlying mechanisms in lung cancer.</p>
<p>Notch signaling is crucial for cell fate and normal embryonic development (<xref ref-type="bibr" rid="B14">Liang et&#x20;al., 2019</xref>). However, recent evidence showed that the Notch family plays a vital role in malignancies (<xref ref-type="bibr" rid="B8">Garcia and Kandel, 2012</xref>). Among the four receptors (Notch1-4) in the Notch family, accumulated evidence has shown the overexpression of Notch3 to be associated with recurrence and metastasis in some cancer types (<xref ref-type="bibr" rid="B12">Kim et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B20">Tang et&#x20;al., 2019</xref>)). In lung cancer, Notch3 has been reported to be associated with poor prognosis (<xref ref-type="bibr" rid="B27">Ye et&#x20;al., 2013</xref>). In gastric cancer, the expression of Notch3 is correlated with the infiltration of immune cells, including CD8<sup>&#x2b;</sup> T&#x20;cells, Tregs, and M2 macrophages (<xref ref-type="bibr" rid="B7">Cui et&#x20;al., 2020</xref>). According to Yan et&#x20;al., Notch3 expression is closely related to the infiltration of M2 macrophage in melanoma tissues (<xref ref-type="bibr" rid="B24">Yan et&#x20;al., 2021</xref>). Although the aforementioned evidence suggests an interaction between Notch3 and immune cells, how Notch3 interacts with immune cells, particularly TANs in lung cancer, remained unexplored.</p>
<p>In this study, we investigated the prognostic role of CD66b &#x2b; TANs in lung adenocarcinoma tissues and found a correlation between the density of TANs and the expression of Notch3. We further investigated the activation of neutrophils by supernatant of cultured lung adenocarcinoma cells and the effect of these TANs on the migration and invasion of lung cancer cells via the Notch3 pathway.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Patients and Specimens</title>
<p>Formalin-fixed-paraffin-embedded (FFPE) tissue specimens were obtained from 100 lung adenocarcinoma patients who underwent surgical operation from 2014 to 2017&#xa0;at the First Affiliated Hospital of Anhui Medical University. Patients included in this study had not received any preoperative adjuvant therapy. All specimens and protocols used in this study were approved by the Ethics Committee of Anhui Medical University (No. 2021H004). The protocols used to be under the ethical standards of the Biomedical Ethics Committee of Anhui Medical University Committee and the 1964 Helsinki Declaration.</p>
</sec>
<sec id="s2-2">
<title>Immunohistochemistry</title>
<p>FFPE samples sliced into 4&#xa0;&#x3bc;m sections were deparaffinized in xylene and graded alcohol, followed by hydration. Antigen retrieval was performed in a pressure cooker containing 0.01&#xa0;M sodium citrate buffer (pH 6.0) for 10&#xa0;min. Tissue sections were incubated with either anti-CD66b (Cat.No.555723, BD Pharmingen) or anti-Notch3 (Cat.No.5276S, Cell Signaling Technology) overnight at 4&#xb0;C. After blocking by endogenous peroxidase for 30&#xa0;min, samples were incubated with the HRP-labeled sheep anti-mouse/rabbit IgG polymer (Cat.No.PV-6000, ZSGB-BIO) for 20&#xa0;min at room temperature. Finally, 3,3&#x2032;-Diaminobenzidine (DAB) was used as chromogen, and the sections were counterstained with hematoxylin.</p>
</sec>
<sec id="s2-3">
<title>Scoring Stained Sections</title>
<p>The density of CD66b &#x2b; neutrophils infiltrating in tumor parenchyma was evaluated as previously reported (<xref ref-type="bibr" rid="B22">Wang et&#x20;al., 2019</xref>). Briefly, CD66b &#x2b; neutrophils were counted under ten random microscopic high power fields (&#xd7;40 objective lenses). According to the median value of all samples, CD66b &#x2b; neutrophils were divided into high-density and low-density groups. Notch3 immunostaining intensity was graded on 0&#x2013;3 scales: 0, absence of staining; 1, weak staining; 2, moderate staining; 3, strong staining. Notch3 positive cancer cells were similarly scored on a scale of 0&#x2013;4 as follows: 0, 0&#x2013;5% positive tumor cells; 1, 6&#x2013;25% positive tumor cells; 2, 26&#x2013;50% positive tumor cells; 3, 51&#x2013;75% positive tumor cells; 4, &#x3e;75% tumor cells. The IHC scores (0&#x2013;12) were obtained by multiplying the staining intensity by the percentage scores; the score &#x3c;4 was negative, &#x2265;4 was positive.</p>
</sec>
<sec id="s2-4">
<title>Isolation and Culture of Neutrophils</title>
<p>Blood obtained from healthy adults was centrifuged at 250&#xa0;g for 15&#x2013;20&#xa0;min. After discarding the plasma, normal saline was added. The diluted blood was carefully added onto a Ficoll solution and centrifuged at 450&#xa0;g for 25&#xa0;min. After discarding the supernatant, RBC lysing buffer was added twice each for 10&#xa0;min. After centrifuging at 1500&#xa0;rpm and discarding the supernatant, the cells were washed twice with PBS, and the cells were resuspended in a serum-free medium.</p>
</sec>
<sec id="s2-5">
<title>Preparation of Tumor Cells Culture Supernatant and NeuCS and Tumor-Associated Neutrophils Culture Supernatant</title>
<p>TCCS (tumor cells culture supernatant) was obtained from the supernatant of A549 and PC-9 lung cancer cells cultured for 48&#xa0;h in a serum-free medium. NeuCS (Neutrophils culture supernatant) was obtained from the supernatant of neutrophils cultured in the serum-free medium for 10&#xa0;h. TANCS (tumor-associated neutrophils culture supernatant) was obtained from the supernatant of neutrophils stimulated by TCCS for 10&#xa0;h.</p>
</sec>
<sec id="s2-6">
<title>Flowcytometry</title>
<p>The viability of TANs and neutrophils was determined by Annexin-V/PI apoptosis detection kits (Biobest). The data were analyzed by FlowJo (Version.&#x20;7.6.1).</p>
</sec>
<sec id="s2-7">
<title>Migration and Invasion Assay</title>
<p>Migration and invasion were performed in an 8&#xa0;&#x3bc;m 24-well culture insert (Corning Company). For invasion assay, Matrigel (BD Company) diluted with the serum-free medium was precoated in the chambers and solidified for 30&#xa0;min at 37&#xb0;C. Lung cancer cells were added to the upper chamber, whereas TANCS, NeuCS, TCCS, and medium were added to the lower chamber, respectively. The cancer cells were cultured for 7 and 12&#xa0;h for migration and invasion assay, respectively. <italic>Cancer</italic> cells attached to the underside of the chambers were fixed and stained. Quantification was performed by evaluating the mean number of cells in five microscopic fields per chamber.</p>
</sec>
<sec id="s2-8">
<title>Wound Healing Assay</title>
<p>The cells were seeded in a 6-well plate at 3.6 &#xd7; 105 cells per well and were cultured overnight. After the next day, 75&#xa0;pmol si-Notch3 or negative control was transfected by using Lipofectamine3000. The transfected cells and untransfected cells were cultured in opti-mem. After 6&#xa0;h, each group of cells was treated with TANCS, NeuCS, TCCS, and medium, respectively. At the same time, the cells were grown to confluence and wounded by dragging a 0.2-ml pipette tip through the monolayer. The extent of cell migration was observed. The rate of wound closure was expressed as a percentage of the initial scraped&#x20;gap.</p>
</sec>
<sec id="s2-9">
<title>Real-Time Polymerase Chain Reaction</title>
<p>RNA was extracted from A549 and PC9 cells using TRIzol reagent (ThermoFisher Scientific), and cDNA was made by reverse transcription with (Evo M-MLV RT Master Mix) according to the manufacturer&#x2019;s instructions. qRT-PCR was performed using (SYBR<sup>&#xae;</sup> Green Pro Taq HS Premix) in 20&#xa0;&#x3bc;L reactions. Primers were designed using Primer3 software and purchased from Sangon Biotech: GAPDH (Sangon Biotech, B662104-0001), Notch3 Fw 5&#x2032;-GCT&#x200b;ACA&#x200b;CTG&#x200b;GAC&#x200b;CTC&#x200b;GCT&#x200b;GT-3&#x2032;, Notch3 Rv 5&#x2032;-AGA&#x200b;CCC&#x200b;CAC&#x200b;CGT&#x200b;TGA&#x200b;CAC&#x200b;AG-3&#x2019;. Reactions were carried out in LightCycler<sup>&#xae;</sup> 96 Application Software (Roche). The cycling program used was 95&#xb0;C for 30 s, followed by 40 cycles of 95&#xb0;C for 5&#xa0;s, 60&#xb0;C for 30&#xa0;s. Data were analyzed using GAPDH as a reference&#x20;gene.</p>
</sec>
<sec id="s2-10">
<title>Western Blotting</title>
<p>Proteins extracted using RIPA buffer were loaded onto SDS&#x2013;polyacrylamide gels and then transferred to PVDF membranes. Membranes were blocked with 5% nonfat milk in TBS-T for 1&#xa0;h at room temperature. Membranes were incubated overnight at 4&#xb0;C with the following primary antibodies: NOTCH3 (Cat.No. 5276S, CellSignaling Technology) and GAPDH (Cat.No. abs132004, Absin). After incubating the membranes with peroxidase-conjugated secondary antibodies (Cat.No. ZB-2301, ZSGB-BIO) for 2&#xa0;h, the reaction was visualized by an enhanced chemiluminescence&#x20;assay.</p>
</sec>
<sec id="s2-11">
<title>Bioinformatics Analysis</title>
<p>The Kaplan&#x2013;Meier plotter ofers a means of readily exploring the impact of a wide array of genes on patient survival in 21 diferent types of cancer, with large sample sizes for the lung adenocarcionma (<italic>n</italic>&#x20;&#x3d; 865) cohorts. We therefore used this database to explore the association between Notch3 expression and outcome in patients with lung cancers (<ext-link ext-link-type="uri" xlink:href="http://kmplot">http://kmplot</ext-link>. com/analysis/).</p>
<p>TIMER (<ext-link ext-link-type="uri" xlink:href="https://cistrome.shinyapps.io/timer/">https://cistrome.shinyapps.io/timer/</ext-link>) is a database designed for the analysis of immune cell infltrates in multiple cancers. This database employs pathological examination-validated statistical methodology to estimate infltration by neutrophils, macrophages, dendritic cells, B&#x20;cells and CD4&#x2b;/CD8&#x2b; T&#x20;cells into tumors. We therefore explore the efect of neutrophils infltration on the survival rate of lung adenocarcinoma patients (<italic>n</italic>&#x20;&#x3d;&#x20;496).</p>
</sec>
<sec id="s2-12">
<title>Statistics</title>
<p>All experiments were carried out three times. The data were expressed as a mean&#x20;&#xb1; standard deviation (SD). Comparison between groups was analyzed by chi-square test. Kaplan-meier was used for survival analysis and <italic>p</italic>-value &#x3c; 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>The Infiltrating of TANs and the Expression of Notch3 in Lung Adenocarcinoma</title>
<p>TANs were observed in both parenchyma and stroma of lung adenocarcinoma (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>). Only those infiltrating in tumor parenchyma were counted. The density of TANs infiltrating in solid and micropapillary adenocarcinoma was significantly higher than that in lepidic adenocarcinoma. The density of TANs showed a positive correlation to the TNM stage but correlated negatively to tumor differentiation (<italic>p</italic>&#x20;&#x3c; 0.05, <xref ref-type="sec" rid="s11">Supplementary Table S1</xref>). Survival analysis showed that the density of TANs was negatively associated with disease-free survival (DFS) (<italic>p</italic>&#x20;&#x3c; 0.05, <xref ref-type="fig" rid="F1">Figure&#x20;1B</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The infiltration of TANs and the expression of Notch3 in lung adenocarcinoma were associated with poor prognosis. <bold>(A)</bold> Representative images for immunohistochemical staining of CD66b and Notch3 in lung adenocarcinoma. <bold>(B)</bold> Survival analysis showed that the density of TANs was negatively correlated with disease-free survival (DFS). <bold>(C)</bold> Survival analysis showed that the expression of Notch3 was negatively correlated to DFS. <bold>(D)</bold> The correlation between the density of TANs and the expression of Notch3 in lung adenocarcinoma.</p>
</caption>
<graphic xlink:href="fmolb-08-762729-g001.tif"/>
</fig>
<p>Notch3 was mainly expressed in the cytoplasm of cancer cells as detected by immunohistochemistry (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>), and the expression of Notch3 in solid adenocarcinoma was significantly higher than that in lepidic adenocarcinoma. The expression of Notch3 was negatively correlated to tumor differentiation (<italic>p</italic>&#x20;&#x3c; 0.05), but showed no significant correlation with gender, age, tumor size, TNM stage, or lymph node metastasis (<xref ref-type="sec" rid="s11">Supplementary Table S1</xref>). Survival analysis showed that the expression of Notch3 was negatively correlated to DFS (<italic>p</italic>&#x20;&#x3c; 0.05, <xref ref-type="fig" rid="F1">Figure&#x20;1C</xref>). In lung adenocarcinoma tissues, the infiltration of TANS was positively correlated with the expression of Notch3 (<italic>p</italic>&#x20;&#x3c; 0.05, <xref ref-type="fig" rid="F1">Figure&#x20;1D</xref>).</p>
</sec>
<sec id="s3-2">
<title>Neutrophils Were Activated to TANs by Supernatant of Cultured Lung Adenocarcinoma Cell Lines</title>
<p>The purity of neutrophils isolated from peripheral blood of healthy adults is 94.0% (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>). The supernatant of cultured A549 and PC-9 lung adenocarcinoma cell lines was used to stimulate neutrophils isolated from the peripheral blood of healthy adults for 10&#xa0;h respectively. Compared with unstimulated neutrophils, a significant increase was observed in the lifespan of neutrophils treated with supernatant of cultured PC-9 (87.3% v. s 38.5%) and A549 (82.0% v. s.38.5%) cell lines (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Supernatant of cultured lung adenocarcinoma cells prolonged the lifespan of neutrophils. <bold>(A)</bold> The purity of neutrophils was analyzed by flow cytometry. <bold>(B)</bold> The viability of neutrophils, neutrophils treated with the supernatant of cultured lung adenocarcinoma cells PC-9 and A549 respectively, was verified using flow cytometry.</p>
</caption>
<graphic xlink:href="fmolb-08-762729-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>The Migration and Invasiveness of Lung Adenocarcinoma Cells Were Promoted by TANs via Notch3</title>
<p>Transwell assays were performed to investigate the effect of TANs on migration and invasiveness of lung adenocarcinoma cells. Compared with lung adenocarcinoma cells that were stimulated by medium, NeuCS, TCCS, the migration and invasion of lung adenocarcinoma cells stimulated by TANCS were significantly higher (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>). The same result was observed on the wound healing assay (<xref ref-type="sec" rid="s11">Supplementary Figure&#x20;S1</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>TANs promoted the migration and invasion of lung adenocarcinoma cells via Notch3. <bold>(A,B)</bold> A549 and PC-9 cells were stimulated with Medium, NeuCS, TCCS, and TANCS, respectively, then the migration and invasion of cells were observed. The expression of Notch3 in A549 and PC-9 cells stimulated with Medium, NeuCS, TCCS, and TANCS, respectively was detected by PCR assay <bold>(C)</bold> and Western blot assay <bold>(D)</bold>. The knockdown effect of specific siRNA (si-Notch3) in A549 and PC-9 cells was verified at both the mRNA <bold>(E)</bold>, by qRT-PCR) and protein levels <bold>(F)</bold>, by western blot). <bold>(G&#x2013;J)</bold> A549-NC, A549-si-Notch3, PC9-NC, and PC9-si-Notch3 cells were stimulated by Medium, NeuCS, TCCS, TANCS, respectively, then the migration <bold>(G&#x2013;H)</bold> and invasion <bold>(I-J)</bold> of the cells were observed.</p>
</caption>
<graphic xlink:href="fmolb-08-762729-g003.tif"/>
</fig>
<p>Notch3 has been widely reported to be associated with cancer development. Therefore, whether Notch3 is involved in the migration and invasion of lung adenocarcinoma cells was explored. Our results showed a significant increase in the expression of Notch3 in lung adenocarcinoma cells treated with TANCS than that treated with medium, NeuCS, and TCCS respectively (<xref ref-type="fig" rid="F3">Figures 3C,D</xref>). However, after knocking down of Notch3, the migration and invasion of lung adenocarcinoma cells stimulated with TANCS were not enhanced (<xref ref-type="fig" rid="F3">Figures 3E&#x2013;J</xref> and <xref ref-type="sec" rid="s11">Supplementary Figure S2</xref>). The results suggested that TANs promoted the migration and invasion of lung adenocarcinoma cells via Notch3.</p>
</sec>
<sec id="s3-4">
<title>Bioinformatics Analysis Showed That TANs and Notch3 Were Associated With Poor Prognosis</title>
<p>The results from the Kaplan-Meier plotter showed that the expression of Notch3 correlated negatively with OS (overall survival), FPS (first-progression, survival), and PPS (post-progression survival) of patients (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>). From the TIMER (<ext-link ext-link-type="uri" xlink:href="http://cistrome.dfci.harvard">http://cistrome.dfci.harvard</ext-link> \.edu/TIMER/, <xref ref-type="fig" rid="F4">Figure&#x20;4B</xref>) analysis, the infiltration of TANs was found to correlate negatively to the OS of patients. Our findings indicated that both TANs and Notch3 were associated with poor prognostic outcomes in patients.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>In lung adenocarcinoma, TANs and Notch3 correlate with poor prognosis. <bold>(A)</bold> The correlation of Notch3 and OS, FPS, PPS in lung adenocarcinoma was analyzed by Bioinformatics data. <bold>(B)</bold> The correlation of TANs and OS in lung adenocarcinoma was analyzed by Bioinformatics&#x20;data.</p>
</caption>
<graphic xlink:href="fmolb-08-762729-g004.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Neutrophils, the most abundant immune cells in peripheral blood (<xref ref-type="bibr" rid="B9">Hidalgo et&#x20;al., 2019</xref>), act as the body&#x2019;s first line of defense against infection and respond to diverse inflammatory cues, including cancer (<xref ref-type="bibr" rid="B19">Shaul and Fridlender, 2019</xref>). Recently, the neutrophil-to-lymphocyte ratio in peripheral blood (pNLR) has been used as a significant prognostic factor for survival in many cancer types, including gastric cancer, melanoma, and lung cancer (<xref ref-type="bibr" rid="B4">Capone et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B29">Zhang et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B18">Sebastian et&#x20;al., 2020</xref>). Although several studies have indicated that pNLR is associated with poor prognosis of cancer patients, the detection of pNLR can be influenced by various factors, including infection, medication, invasive surgery (<xref ref-type="bibr" rid="B16">Mouchemore et&#x20;al., 2018</xref>).</p>
<p>In recent years, neutrophils infiltrated into tumors have gained attention as suitable biomarkers due to their ability to predict the progression of several cancer types. In gastric cancer, TANs are negatively correlated to the DFS of patients (<xref ref-type="bibr" rid="B6">Cong et&#x20;al., 2020</xref>). In pancreatic neuroendocrine tumors, TANs have been shown to correlate negatively to the PFS and OS of patients (<xref ref-type="bibr" rid="B28">Zhang et&#x20;al., 2020</xref>). Herein, we found the high density of TANs to be associated with poor prognostic outcomes in both immunohistochemical and Bioinformatics analysis. Our <italic>in&#x20;vitro</italic> experiments revealed the abilities of TANs to promote the migration and invasion of A549 and PC-9 cells, which is consistent with the results found in other studies (<xref ref-type="bibr" rid="B6">Cong et&#x20;al., 2020</xref>). Taken together, our findings suggest that the infiltration of TANs in lung adenocarcinoma can be further evaluated to predict the metastasis of tumor&#x20;cells.</p>
<p>Several mechanisms regulating the effect of TANs on the metastasis of tumor cells have been reported. In gastric cancer, TANs promoted the migration and invasion of tumor cells by secreting IL-17a (<xref ref-type="bibr" rid="B13">Li et&#x20;al., 2019</xref>). In colon cancer, TANs promoted the metastasis of tumor cells through the CCL15-CCR2 axis (<xref ref-type="bibr" rid="B23">Yamamoto et&#x20;al., 2017</xref>). In our previous study, breast cancer cells induced neutrophil extracellular traps (NETs) by secreting IL-8, and these NETs promoted the migration of tumor cells (<xref ref-type="bibr" rid="B3">Cai et&#x20;al., 2020</xref>). However, the tumor-promoting mechanisms of TANs with particular emphasis on lung cancer cell behavior are unclear.</p>
<p>According to numerous reports, notch-3 is associated with the development of cancer, including lung cancer (<xref ref-type="bibr" rid="B1">Aburjania et&#x20;al., 2018</xref>). Ye and her co-workers discovered that Notch3 was associated with lymph node metastasis and poor prognosis (<xref ref-type="bibr" rid="B27">Ye et&#x20;al., 2013</xref>). Therefore, we speculated that if TANs promoted the migration and invasion of lung cancer via Notch3. To verify this, we detected the expression of Notch3 in lung cancer by immunohistochemical staining and analyzed its correlation with TANs. We found Notch3 to be associated with poor prognosis and correlated positively with the infiltration of TANs. Results from our <italic>in&#x20;vitro</italic> experiments demonstrated that TANs increased the expression of Notch3 in lung cancer cells. We further noted inhibition of the migration and invasion of lung cancer cells mediated by TANs after the knockdown of Notch3. Our findings suggest an interaction between Notch3 and neutrophils in the lung cancer tumor microenvironment. This is consistent with the results of Yang et&#x20;al., who found TANs to promote the progression of ovarian cancer cells via the Notch3 pathway (<xref ref-type="bibr" rid="B26">Yang et&#x20;al., 2020</xref>).</p>
<p>Collectively, our study indicated that lung adenocarcinoma cells promote self-invasion and self-migration by activating neutrophils to upregulate the Notch3 expression of cancer cells. Our study has given new insights into the pathogenesis of lung cancer. Targeting TANs with Notch3 could be a new diagnostic and therapeutic strategy for treating lung cancer.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by Ethics Committee of Anhui Medical University (No. 2021H004). The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>QW, JX, and WP designed the experiments; WP performed the experiments and YS offered help. WP contributed to certain key experiments. WP prepared the figures; YS, HX, YY, LC, YW were involved in specific experiments; QW, WP, and LK wrote the manuscript; QW funded the work and provided overall research supervision.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>We acknowledge the funding support from The Academic and Technological Leaders and Reservoirs Foundation of Anhui Province for the 2019 academic year. We also acknowledge the support offered by the Center for Scientific Research of Anhui Medical University.</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>Thank JX and his research group for providing A549 and PC9 cell lines from the Department of Immunology, Anhui Medical University. Thanks to Meijuan Zheng from the laboratory of the First Affiliated Hospital of Anhui Medical University for her help in flow cytometry.</p>
</ack>
<sec id="s11">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2021.762729/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmolb.2021.762729/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image2.jpg" id="SM1" mimetype="application/jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table1.pdf" id="SM2" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image1.jpg" id="SM3" mimetype="application/jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aburjania</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Whitt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jaskula&#x2010;Stzul</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>J.&#x20;B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The Role ofNotch3in Cancer</article-title>. <source>Oncol.</source> <volume>23</volume>, <fpage>900</fpage>&#x2013;<lpage>911</lpage>. <pub-id pub-id-type="doi">10.1634/theoncologist.2017-0677</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bade</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Dela Cruz</surname>
<given-names>C. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Lung Cancer 2020</article-title>. <source>Clin. Chest Med.</source> <volume>41</volume>, <fpage>1</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccm.2019.10.001</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Boafo Kwantwi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Breast Cancer Cells Promote Self-Migration by Secreting Interleukin 8 to Induce NET Formation</article-title>. <source>Gene</source> <volume>754</volume>, <fpage>144902</fpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2020.144902</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capone</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Giannarelli</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mallardo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Madonna</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Festino</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Grimaldi</surname>
<given-names>A. M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients with Advanced Melanoma Treated with Nivolumab</article-title>. <source>J.&#x20;Immunotherapy Cancer</source> <volume>6</volume>, <fpage>74</fpage>. <pub-id pub-id-type="doi">10.1186/s40425-018-0383-1</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carus</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ladekarl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hager</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pilegaard</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Donskov</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Tumor-associated Neutrophils and Macrophages in Non-small Cell Lung Cancer: No Immediate Impact on Patient Outcome</article-title>. <source>Lung Cancer</source> <volume>81</volume>, <fpage>130</fpage>&#x2013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/j.lungcan.2013.03.003</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>CD66b &#x2b; Neutrophils and &#x3b1;&#x2010;SMA &#x2b; Fibroblasts Predict Clinical Outcomes and Benefits from Postoperative Chemotherapy in Gastric Adenocarcinoma</article-title>. <source>Cancer Med.</source> <volume>9</volume>, <fpage>2761</fpage>&#x2013;<lpage>2773</lpage>. <pub-id pub-id-type="doi">10.1002/cam4.2939</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>NOTCH3 Is a Prognostic Factor and Is Correlated with Immune Tolerance in Gastric Cancer</article-title>. <source>Front. Oncol.</source> <volume>10</volume>, <fpage>574937</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2020.574937</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kandel</surname>
<given-names>J.&#x20;J.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Notch: a Key Regulator of Tumor Angiogenesis and Metastasis</article-title>. <source>Histol. Histopathol</source> <volume>27</volume>, <fpage>151</fpage>&#x2013;<lpage>156</lpage>. <pub-id pub-id-type="doi">10.14670/HH-27.151</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hidalgo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chilvers</surname>
<given-names>E. R.</given-names>
</name>
<name>
<surname>Summers</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Koenderman</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The Neutrophil Life Cycle</article-title>. <source>Trends Immunol.</source> <volume>40</volume>, <fpage>584</fpage>&#x2013;<lpage>597</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2019.04.013</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirsch</surname>
<given-names>F. R.</given-names>
</name>
<name>
<surname>Scagliotti</surname>
<given-names>G. V.</given-names>
</name>
<name>
<surname>Mulshine</surname>
<given-names>J.&#x20;L.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Curran</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.-L.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Lung Cancer: Current Therapies and New Targeted Treatments</article-title>. <source>The Lancet</source> <volume>389</volume>, <fpage>299</fpage>&#x2013;<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(16)30958-8</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname>
<given-names>H. K.</given-names>
</name>
<name>
<surname>Donskov</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Marcussen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nordsmark</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lundbeck</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>von der Maase</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Presence of Intratumoral Neutrophils Is an Independent Prognostic Factor in Localized Renal Cell Carcinoma</article-title>. <source>Jco</source> <volume>27</volume>, <fpage>4709</fpage>&#x2013;<lpage>4717</lpage>. <pub-id pub-id-type="doi">10.1200/jco.2008.18.9498</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>A.-R.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>J.-Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K.-i.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>T.-H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Correlation of ALDH1 and Notch3 Expression: Clinical Implication in Ovarian Carcinomas</article-title>. <source>J.&#x20;Cancer</source> <volume>8</volume>, <fpage>3331</fpage>&#x2013;<lpage>3342</lpage>. <pub-id pub-id-type="doi">10.7150/jca.18955</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Tumor-associated Neutrophils Induce EMT by IL-17a to Promote Migration and Invasion in Gastric Cancer Cells</article-title>. <source>J.&#x20;Exp. Clin. Cancer Res.</source> <volume>38</volume>, <fpage>6</fpage>. <pub-id pub-id-type="doi">10.1186/s13046-018-1003-0</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>S.-j.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.-g.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.-q.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Notch Signaling in Mammalian&#x20;Intestinal Stem Cells: Determining Cell Fate and Maintaining Homeostasis</article-title>. <source>Cscr</source> <volume>14</volume>, <fpage>583</fpage>&#x2013;<lpage>590</lpage>. <pub-id pub-id-type="doi">10.2174/1574888x14666190429143734</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masucci</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Minopoli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Carriero</surname>
<given-names>M. V.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy</article-title>. <source>Front. Oncol.</source> <volume>9</volume>, <fpage>1146</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2019.01146</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mouchemore</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>J.&#x20;A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Neutrophils, G-CSF and Their Contribution to Breast Cancer Metastasis</article-title>. <source>Febs J.</source> <volume>285</volume>, <fpage>665</fpage>&#x2013;<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1111/febs.14206</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rakaee</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Busund</surname>
<given-names>L.-T.</given-names>
</name>
<name>
<surname>Paulsen</surname>
<given-names>E.-E.</given-names>
</name>
<name>
<surname>Richardsen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Al-Saad</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Prognostic Effect of Intratumoral Neutrophils across Histological Subtypes of Non-small Cell Lung Cancer</article-title>. <source>Oncotarget</source> <volume>7</volume>, <fpage>72184</fpage>&#x2013;<lpage>72196</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.12360</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sebastian</surname>
<given-names>N. T.</given-names>
</name>
<name>
<surname>Raj</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Barney</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Brownstein</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Grecula</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Association of Pre- and Posttreatment Neutrophil-Lymphocyte Ratio with Recurrence and Mortality in Locally Advanced Non-small Cell Lung Cancer</article-title>. <source>Front. Oncol.</source> <volume>10</volume>, <fpage>598873</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2020.598873</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaul</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Fridlender</surname>
<given-names>Z. G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Tumour-associated Neutrophils in Patients with Cancer</article-title>. <source>Nat. Rev. Clin. Oncol.</source> <volume>16</volume>, <fpage>601</fpage>&#x2013;<lpage>620</lpage>. <pub-id pub-id-type="doi">10.1038/s41571-019-0222-4</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Overexpression of Notch3 Is Associated with Metastasis and Poor Prognosis in Osteosarcoma Patients</article-title>. <source>Cmar</source> <volume>Vol. 11</volume>, <fpage>547</fpage>&#x2013;<lpage>559</lpage>. <pub-id pub-id-type="doi">10.2147/cmar.s185495</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>The Clinical Significance of Tumor-Infiltrating Neutrophils and Neutrophil-To-Cd8&#x2b; Lymphocyte Ratio in Patients with Resectable Esophageal Squamous Cell Carcinoma</article-title>. <source>J.&#x20;Transl Med.</source> <volume>12</volume>, <fpage>7</fpage>. <pub-id pub-id-type="doi">10.1186/1479-5876-12-7</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Tumor-Contacted Neutrophils Promote Metastasis by a CD90-TIMP-1&#x20;Juxtacrine-Paracrine Loop</article-title>. <source>Clin. Cancer Res.</source> <volume>25</volume>, <fpage>1957</fpage>&#x2013;<lpage>1969</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.ccr-18-2544</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamamoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kawada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Itatani</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Inamoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Okamura</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Iwamoto</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1&#x2b; Tumor-Associated Neutrophils through CCL15-CCR1 Axis</article-title>. <source>Clin. Cancer Res.</source> <volume>23</volume>, <fpage>833</fpage>&#x2013;<lpage>844</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.ccr-16-0520</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Coexpressed Genes that Promote the Infiltration of M2 Macrophages in Melanoma Can Evaluate the Prognosis and Immunotherapy Outcome</article-title>. <source>J.&#x20;Immunol. Res.</source> <volume>2021</volume>, <fpage>6664791</fpage>. <pub-id pub-id-type="doi">10.1155/2021/6664791</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>S.-C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.-Q.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.-L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Tumor-associated Immune Factors Are Associated with Recurrence and Metastasis in Non-small Cell Lung Cancer</article-title>. <source>Cancer Gene Ther.</source> <volume>24</volume>, <fpage>57</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1038/cgt.2016.40</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Tumour-associated Neutrophils Orchestrate Intratumoural IL-8-driven Immune Evasion through Jagged2 Activation in Ovarian Cancer</article-title>. <source>Br. J.&#x20;Cancer</source> <volume>123</volume>, <fpage>1404</fpage>&#x2013;<lpage>1416</lpage>. <pub-id pub-id-type="doi">10.1038/s41416-020-1026-0</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>Y.-z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.-h.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>X.-y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.-l.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.-l.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>B.-w.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Notch3 Overexpression Associates with Poor Prognosis in Human Non-small-cell Lung Cancer</article-title>. <source>Med. Oncol.</source> <volume>30</volume>, <fpage>595</fpage>. <pub-id pub-id-type="doi">10.1007/s12032-013-0595-7</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W. Q.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T. J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Tumor-Infiltrating Neutrophils Predict Poor Survival of Non-functional Pancreatic Neuroendocrine Tumor</article-title>. <source>J.&#x20;Clin. Endocrinol. Metab.</source> <volume>105</volume>, <fpage>196</fpage>. <pub-id pub-id-type="doi">10.1210/clinem/dgaa196</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Y. P.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>C. X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L. Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M. B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Prognostic Value of Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio in Gastric Cancer</article-title>. <source>Medicine (Baltimore)</source> <volume>97</volume>, <fpage>e0144</fpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000010144</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>S.-L.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.-J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z.-Q.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.-W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>E.-B.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib</article-title>. <source>Gastroenterology</source> <volume>150</volume>, <fpage>1646</fpage>&#x2013;<lpage>1658</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2016.02.040</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>